z-logo
Premium
Clinical benefit of depth of response for relapsed/refractory multiple myeloma patients treated on clinical trials: retrospective analysis from two tertiary centres
Author(s) -
Chan Esther H. L.,
DeSilva Dunnya,
Lin Adeline H. F.,
Rabin Neil,
Wechalekar Ashutosh,
Popat Rakesh,
Chng Wee Joo,
Yong Kwee L.
Publication year - 2019
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.15743
Subject(s) - medicine , clinical trial , multiple myeloma , oncology , refractory (planetary science) , progression free survival , surgery , overall survival , physics , astrobiology

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom